Recent Research Grants

  • Rhythm Evaluation for AntiCoagulaTion for Atrial Fibrillation (REACT AF). Anne Curtis (Co-Investigator). NIH. $66,278. 8/1/2023-7/1/2029.
  • Posttranslational modifications of glucocorticoid receptor associated with drug resistance in prostate cancer. Remi Adelaiye-Ogala (Principal Investigator). NCI/NIH. 4/1/2024-5/1/2029.
  • Cardiovascular Risk Reduction for Adults with Food Insecurity Using Structured Incentives (CVD-FIT). Jennifer Campbell (Co-Investigator). NIH/NIMHD R01MD018721. 9/1/2024-3/1/2029.
  • Cardiovascular Risk Reduction for Adults with Food Insecurity Using Structured Incentives (CVD-FIT). Leonard Egede (Co-Investigator). NIH/NIHMHD. 9/1/2024-3/1/2029.
  • VA Merit Review, 2IO1BX002659, Preventing and Reversing Interstitial Fibrosis in HFpEF. John Canty, Jr. (Principal Investigator). Department of Veterans Affairs. $709,984. 7/1/2020-6/1/2028.
  • NIH/NIAID (Morse) HIV/AIDS Clinical Trial Unit. Andrew Talal (Co-Principal Investigator). 12/1/2013-4/1/2028.
  • The Role of Structural Racism on Disparities in Clinical Outcomes for Diabetes: A Mixed Methods Study. Jennifer Campbell (Co-Investigator). NIH/NIDDK R01 DK135838. 8/1/2023-4/1/2028.
  • The Role of Structural Racism on Disparities in Clinical Outcomes for Diabetes: A Mixed Methods Study. Leonard Egede (Co-Investigator). NIH/NIDDK. 8/1/2023-4/1/2028.
  • UW Practice-based Suicide Prevention Research Center. Andrew Rogers (Co-Investigator). National Institute on Mental Health. 2/1/2023-2/1/2028.
  • Determining the value of PBP 7/8 as an antimicrobial target for XDR-A. baumannii. Thomas Russo (Principal Investigator). Veterans Administration. $1,359,244. 10/1/2019-9/1/2027.
  • Enhancing the translational potential of therapeutic exosomes for ischemic heart disease. Jennifer Lang (Principal Investigator). VA. $709,818. 10/1/2023-9/1/2027.
  • Training the Next Generation of Physician Scientists T35 Training Grant. Timothy Murphy (Principal Investigator). NIAID. $293,309. 9/1/2022-8/1/2027.
  • Mab Passive Vaccination against Acinetobacter baumannii. Thomas Russo (Co-Investigator). NIAID/NIH. $485,053. 9/1/2022-8/1/2027.
  • Targeting complement to enhance antitumor immunity and control malignant effusions in patients with recurrent epithelial ovarian cancer. Brahm Segal (Principal Investigator). NCI. $3,310,823. 8/1/2022-8/1/2027.
  • Novel Combination Therapies to Combat Hypermutable Carbapenem-Resistant P. aeruginosa. Thomas Russo (Co-Investigator). NIAID/NIH. 5/1/2022-4/1/2027.
  • The benefits of nicotinamide riboside upon cognition and sleep in older adults. M. Jeffery Mador (Co-Investigator). NIH. 3/1/2023-3/1/2027.
  • Impact of Structural Racism on Hospital/Clinic Closures, Community Assets, and Health Outcomes in Urban Communities. Jennifer Campbell (Co-Investigator). NIH/NIMHD R01 MD018012. 7/1/2023-1/1/2027.
  • Impact of Structural Racism on Hospital/Clinic Closures, Community Assets, and Health Outcomes in Urban Communities. Leonard Egede (Principal Investigator). NIH/NIMHD?. 7/1/2023-1/1/2027.
  • Impacts of Nicotinamide Riboside on functional capacity and muscle physiology in older veterans. Nikhil Satchidanand (Co-Investigator). Veterans Affairs. 1/1/2022-12/1/2026.
  • Conditional Cash Transfer Intervention to Improve Health Outcomes among Inner-City African Americans with T2DM. Jennifer Campbell (Principal Investigator). NIH/NIDDK K01 DK131319. 1/1/2022-12/1/2026.